Outpatient OUD Treatment

graphic image

Training slides covering the epidemiology of opioid use and addiction at the national and state levels, with a focus on the impact of COVID-19; key principles of addiction medicine; FDA approved treatment options for opioid use disorder (OUD), with a focus on various buprenorphine formulations; the expansion of tele-behavioral health treatment for OUD; and a review of adjunct medications for providing care to individuals with OUD including PrEP, PEP, and Naloxone.

Documents with preview

Browse more